Pulmonology and CritCare Flashcards

1
Q

most important initial screening test for pulmonary hypertension

A

echocardiogram with bubble study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

gold standard both to establish the diagnosis of PH and to guide selection of appropriate medical therapy

A

Right heart catheterization (RHC) with pulmonary vasodilator testing remain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The definition of precapillary PH or PAH requires (1) an increased mean PAP (____) (2) a pulmonary capillary wedge pressure (PCWP), left atrial pressure, or left ventricular end-diastolic pressure (LVEDP) ≤____ (3) PVR > Wood units.

A
  1. mPAP >20 mmHg
  2. <=15 mmHg
  3. > 3

**based on ch 283, the mean pulmonary artery pressure (mPAP) used to bdiagnose PH has been lowered from ≥25 mmHg to >20 mmHg.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In pulmonary hypertension, A decrease in mPAP by _____ to an absolute level _____ without a decrease in CO is defined as a positive pulmonary vasodilator response, and responders are considered for long-term treatment with calcium channel blockers (CCB)

A

≥10 mmHg
≤40 mmHg

Vasoreactivity testing should be reserved mainly for patients with idiopathic or hereditary PAH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A soluble guanylyl cyclase stimulator approved for treatment of PAH

A

Riociguat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Examples of false-negative findings in PET scan for lung tumor (3)

A

carcinoid tumors
bronchioloalveolar cell carcinomas
or in lesions <1 cm in which the required threshold of metabolically active malignant cells is not present for PET diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Examples of false positive PET scan for lung tumor

A

pneumonia
granulomatous diseases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

gold standard for mediastinal staging

A

Mediastinoscopy

however, transbronchial needle aspiration (TBNA) allows sampling from the lungs and surrounding lymph nodes without the need for surgery or general anesthesia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Asthma can present at any age, with a peak age of ____

A

3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

major risk factor for asthma

A

Atopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

“hygiene hypothesis” proposes that lack of infections in early childhood preserves the ___ cell bias at birth, whereas exposure to infections and endotoxin results in a shift toward a predominant protective ___ immune response.

A

Th2
Th1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Exercise-induced asthma (EIA) typically begins after exercise has ended, and recovers spontaneously within about ____.

A

30 min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

EIA is best prevented by regular treatment with ______

A

It may be prevented by prior administration of β2 -agonists and antileukotrienes, but is best prevented by regular treatment with ICS, which reduce the population of surface mast cells required for this response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Definition of reversibility in asthma

A

Reversibility is demonstrated by a >12% and 200-mL increase in FEV1 15 min after an inhaled short-acting β2 -agonist (SABA; such as inhaled albuterol 400 μg) or in some patients by a 2–4 week trial of oral corticosteroids (OCS) (prednisone or prednisolone 30–40 mg daily)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The increased airway hyperresponsiveness (AHR) is normally measured by methacholine or histamine challenge with calculation of the provocative concentration that reduces FEV1 by _____

A

20% (PC20)

with a value ≤400 μg indicative of airway reactivity

Challenge with exercise and/or cold, dry air can be performed, with a positive response recorded if there is a ≥10% drop in FEV1 from baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

most effective controllers for asthma

A

ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Among the 4 characteristics symptoms of asthma, which 2 would need to be present 2x/week to qualify for partially controlled/ uncontrolled asthma

A

Daytime symptoms
Need of reliever

Limitation of activities and nighttime awakening need to be present at least once a week only for it to qualify for partually controlled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

For acute severe asthma, a high concentration of oxygen should be given by face mask to achieve oxygen saturation of >____.

A

90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

mainstay of treatment for acute severe asthma

A

high doses of SABA given either by nebulizer or via a MDI with a spacer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Definition of corticosteroid resistant asthma

A

failure to respond to a high dose of oral prednisone/prednisolone (40 mg once daily over 2 weeks), ideally with a 2-week run-in with matched placebo.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

The mainstay of treatment for Hyeprsensitivity pneumonitis is _______

A

antigen avoidance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hypereosinophilic syndromes (HES) constitute a heterogeneous group of disease entities manifest by persistent eosinophilia >_____ eosinophils/ μL in association with end organ damage or dysfunction, in the absence of secondary causes of eosinophilia

A

1500

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How do you differentiate Allergic bronchopulmonary aspergillosis (ABPA) from asthma?

A

ABPA is a distinct diagnosis from simple asthma, characterized by prominent peripheral eosinophilia and elevated circulating levels of IgE (>417 IU/mL).

Central bronchiectasis is described as a classic finding on chest imaging in ABPA but is not necessary for making a diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

most common cancer associated with asbestos exposure

A

Lung cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Occupational disease that may present with crazy paving on HRCT

A

Silicosis = with characteristic HRCT pattern known as “crazy paving”

Calcification of hilar nodes may occur in as many as 20% of cases and produces a characteristic “eggshell” pattern.

mnemonic: pag crazy ka, silly ca (silica)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Caplan syndrome is the combination of ___ and ___

A

Caplan syndrome, first described in coal miners but subsequently in patients with silicosis, is the combination of pneumoconiotic nodules and seropositive rheumatoid arthritis.

Remember na Caplan is seen in coal workers pneumoconiosis and silicosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

The major site of increased resistance in most individuals with COPD is in airways____ diameter

A

≤2 mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Emphysema most frequently associated with cigarette smoking, is characterized by enlarged air spaces found (initially) in association with respiratory bronchioles.

A

Centrilobular emphysema

usually most prominent in the upper lobes and superior segments of lower lobes and is often quite focal.

C-C (cigarette, centrilobular)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Type of emphysema is commonly observed in patients with α1 AT deficiency

A

Panlobular emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

The 3 most common symptoms in COPD ____

A

cough, sputum production, and exertional dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

The change in pH with Pco2 is _____/10 mmHg acutely and ____/10 mmHg in the chronic state.

A

0.08 units
0.03 units (c-3rd letter of the alphabet, c- chronic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

The main role of ICS in COPD is to _____

A

reduce exacerbations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

the only pharmacologic therapy demonstrated to unequivocally decrease mortality rates in patients with COPD.

A

Supplemental O2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

For COPD patients with resting hypoxemia (resting O2 saturation ___ in any patient or ___ with signs of pulmonary hypertension or right heart failure), the use of O2 has been demonstrated to have a significant impact on mortality

A

≤88%
≤89%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

The strongest single predictor of exacerbations is a _______

A

history of a previous exacerbation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Bacteria frequently implicated in COPD exacerbations include (3)

A

Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

a pathologic hallmark of interstitial pulmonary fibrosis

A

Usual interstitial pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Diseases that satisfies the exudative criteria using Light’s criteria and would have a glucose < 60 mg/dL

A

Malignancy
Bacterial infections
Rheumatoid pleuritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Light’s criteria misidentify )___% of transudates as exudates.

A

~25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

o If one or more of the exudative criteria are met and the patient is clinically thought to have a condition producing a transudative effusion, the difference between _________ should be measured.

A

protein levels in the serum and the pleural fluid

If this gradient is >31 g/L (3.1 g/dL), the exudative categorization by these criteria can be ignored because almost all such patients have a transudative pleural effusion.

You can also compute for serum - pleural fluid albumin. Cut off is 1.2 g/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

A pleural fluid N-terminal pro-brain natriuretic peptide (NT-proBNP) >_____ is virtually diagnostic that the effusion is secondary to congestive heart failure.

A

1500 pg/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Factors indicating the likely need for a procedure more invasive than a thoracentesis (in increasing order of importance) include:

A
  1. Loculated pleural fluid
  2. Pleural fluid pH< 7.20
  3. Pleural fluid glucose <3.3 mmol/L (60 mg/dL)
  4. Positive Gram stain or culture of the pleural fluid
  5. Presence of gross pus in the pleural space
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Pulmonary embolism - exudative or transudative?

A

exudative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

How do you diagnose ptb using pleural fluid studies?

A

The diagnosis is established by demonstrating high levels of TB markers in the pleural fluid (adenosine deaminase >40 IU/L or interferon γ >140 pg/mL).

mnemonic (1nter40n- y) IFN-y –> 140

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

pleural TAG level to diagnose chylothorax

A

Thoracentesis reveals milky fluid, and biochemical analysis reveals a triglyceride level that exceeds 1.2 mmol/L (110 mg/dL).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

The most common cause of chylothorax is _____

A

trauma

most commonly thoracic surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

The initial recommended treatment for primary spontaneous pneumothorax is ______

A

simple aspiration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Criteria for diagnosing OSA

A

Diagnosis requires the patient to have
(1) either symptoms of nocturnal breathing disturbances (snoring, snorting, gasping, or breathing pauses during sleep) or daytime sleepiness or fatigue that occurs despite sufficient opportunities to sleep and is unexplained by other medical problems; and
(2) five or more episodes of obstructive apnea or hypopnea per hour of sleep

OSAHS also may be diagnosed in the absence of symptoms if the AHI is >15 episodes/h.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

The most common daytime symptom in OSA is _____

A

excessive sleepiness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

The gold standard for diagnosis of OSAHS is

A

overnight polysomnogram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Definition of hypopnea

A

30% reduction in airfow for at least 10 s and commonly results in a ≥3% drop in oxygen saturation and/or a brain cortical arousal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

standard medical therapy with the highest level of evidence for efficacy for OSA

A

CPAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

What constitutes qSOFA

A

respiratory rate >22, altered mental status, or systolic blood pressure <100

Needs to fulfill 2/3 to diagnose sepsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Criteria for stopping spontaneous breathing trial

A

 The spontaneous breathing trial is declared a failure and stopped if any of the fd occur:
o (1) respiratory rate >35/min for >5 min,
o (2) O2 saturation <90%
o (3) HR > 140/min or a 20% increase or decrease from baseline,
o (4) systolic blood pressure 180 mmHg, or
o (5) increased anxiety or diaphoresis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Reason why H2 blockers are preferred for PPI in iCU setting

A

Histamine receptor-2 antagonists are preferred over proton pump inhibitors because the latter are associated with increased incidence of C. difficile colitis and pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

The most common cause of distributive shock is

A

sepsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Type of shock with dec CVP, PCWP, SVR but inc CO

A

Distributive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Type of shock with dec CVP, PCWP, CO but inc SVR

A

Hypovolemic

key difference between hypovolemic and distributive is the CO and SWR

CO is dec in hypovolemic but inc in distributive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Type of shock that will have inc CVP, PCWP, SVR but dec CO

A

Cardiogenic/ Obstructive however obstructive may present with either inc or dec PCWP. The rest of the parameters are same as cardiogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

The shock index (SI) is defined as ______

A

defined as the HR/systolic blood pressure (SBP) with a normal SI being 0.5–0.7.

An elevated SI (>0.9) has been proposed to be a more sensitive indicator of transfusion requirement and of patients with critical bleeding among those with hypovolemic (hemorrhagic) shock than either HR or BP alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

In sepsis ____ are the most common gram-positive isolates, while _ are the most common gram-negative isolates.

A

S. aureus and S. pneumoniae

E. coli, Klebsiella species, and Pseudomonas aeruginosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

every 1-h delay of antibiotic administration among px w/ sepsis, a _____ increase in the odds of in-hospital death is reported

A

3–7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Why is dopamine avoided as first line therapy for MI with cardiogenic shock?

A

Dopamine should be avoided as first-line therapy for MI with CS based on hemodynamic and proarrhythmogenic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

While several prior trials demonstrated that mechanical ventilation in the prone position improved arterial oxygenation without a mortality benefit, a recent trial demonstrated a significant reduction in 28-day mortality with prone positioning (32.8 to 16%) for patients with severe ARDS with Pao2/Fio2 of _____

A

Pao2 /Fio2 < 150 mm Hg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

The only class A recommendation therapy for ARDS

A

Low TV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

5 Class B recommendations for ARDS

A

High PEEP
Minimize LA pressures
Prone position
ECMO
Early muscular blockade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Definition of moderate ARDS

A

PF ratio 100 to <= 200

Hence mild = <300
severe <= 100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

The most important group of patients who benefit from a trial of NIV are those with ____ and ____

A

COPD exacerbations and respiratory acidosis (pH <7.35)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

ventilatory weaning task force cites the ff conditions as indicating amenability to weaning:

PEEP
Fio2
Maximal inspiratory pressure
Minute ventilation

A

(1) Lung injury is stable or resolving;
(2) gas exchange is adequate, with low PEEP (< 8 cmH2 O) and Fio2 (0.5);
(3) hemodynamic variables are stable, and patient is no longer receiving vasopressors;
(4) the patient is capable of initiating spontaneous breaths.
(5) Maximal inspiratory pressure < -30 cm H2O
(6) Minute ventilation < 10 LPM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

According to NTP If resources are limited, you have the option to prioritize those with TB risk factors as primary clients for chest X-ray screening.

Risk factor include:

A

a. contacts of TB patients
b. those ever treated for TB (i.e. with history of previous TB treatment);
c. people living with HIV (PLHIV);
d. elderly (> 60 years old);
e. diabetics;
f. smokers;
g. health-care workers;
h. urban and rural poor (indigents); and
i. those with other immune-suppressive medical conditions (silicosis, solid organ transplant, connective tissue or autoimmune disorder, end-stage renal disease, chronic corticosteroid use, alcohol or substance abuse, chemotherapy or other forms of medical treatment for cancer).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Screening by chest X-ray may be done every ____ for patients labeled as presumptive TB

A

1x a yr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Diagnostic test that should be requested for presumptive TB with unknown HIV status

A

Request Xpert MTB Rif Test
(SM/TB LAMP if Xpert not available)

Xray not needed . only for those for screening but without symptoms

if HIV +, need to do BOTH symptom and CXR screening so this time even if asymptomatic, need to do cxr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Among TB contacts, Who should be screened with CXR

A

If drug sensitive, All 5 years old and above (symptom screening only for < 5 years old)
If chest X-ray not available, do symptom screening

If drug resistant, ALL contacts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Diagnostic test for screening TB contacts

A

Gene Xpert

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

How frequent should you ff up TB contacts

A

every 6 months for 2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

primary diagnostic test for PTB and EPTB in adults and children.

A

rapid diagnostic test (RDT), such as Xpert MTB/RIF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Can you use saliva as sample for Gene Xpert for screening for PTB?

A

For Xpert, testing should be performed on any collected spot sputum sample regardless whether it is sputum or saliva.

For SM, examine the specimen to see that it is not just saliva. Mucus from the nose and throat, and saliva from the mouth are not good specimens. Repeat the process if necessary.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Interpretation for these results for Gene Xpert

T
RR
TI
N
I

A

T = Mycobacterium tuberculosis (MTB) detected, rifampicin resistance not detected.
RR = MTB detected, rifampicin resistance detected.
TI= MTB detected, rifampicin resistance indeterminate.
N= MTB not detected.
I= Invalid/no result/error.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

In which cases of should you repeat Gene xpert in patients with RR as initial result

A

For those who are at low risk for MDR-TB (i.e. new TB cases who are not DR-TB contacts) but with an Xpert result ofRR MTB detected with rifampicin resistance, the patient can be classified as bacteriologically confirmed TB (BCTB), but recollect a fresh sputum sample for repeat the Xpert MTB/RIF test and follow the second result on Rifampicin
resistance for the treatment decision.

However, in PLHIV in which mortality from the TB co-infection is high, there is no need to repeat the Xpert test as it will result in significantly delaying initiation of treatment.
The patient may be treated based on the result of the initial test.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

How do you differentiate the ff?

Monoresistant TB
Polydrug resistant TB
MDR TB
XDR TB

A

Monoresistant TB
with resistance to one first-line anti-TB drug, except rifampicin whether bacteriologically confirmed or clinically diagnosed

Polydrug resistant TB
with resistance to more than one first-line anti-TB drug, other than both isoniazid and rifampicin, whether bacteriologically confirmed or clinically diagnosed

MDR TB
Positive for MTB complex with resistance to at least both isoniazid and rifampicin

XDR TB
Positive for MTB complex with resistance to any fluoroquinolone(FQ) and to at least one second-line injectable drug (e.g. amikacin,streptomycin), in addition to multidrug resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Regimen 1 for DS TB

A

2HRZE/4HR

for PTB or EPTB (except central nervous system [CNS], bones, joints) whether new or retreatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Regimen 2 for DS TB

A

2HRZE/10HR

for EPTB of CNS, bones, joints whether new or retreatment,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Body weight range that requires 3 tablets of TB meds

A

38-54 kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Body weight range that requires 4 tablets of TB meds

A

55-70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Screening used for DM in TB patients

A

If not a known diabetic, screen all TB patients ≥ 25 years old for diabetes using a fasting or random plasma blood glucose test (Cut-off level ≥ 7 mmol/L or 126 mg/dl for fasting; 11.1 mmol/L or 200 mg/dl for random).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

When should Antiretroviral drugs be given in px with TB and HIV?

A

TB treatment should be initiated first, followed by ART as soon as possible within the first eight weeks of treatment.

If with profound immunosuppression (e.g. CD4
counts less than 50 cells/mm3), HIV-positive TB patients should receive ART within the first
two weeks of initiating TB treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

What TB drug may have a major side effect of psychosis and convulsion?

A

Isoniazid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

What TB drug may have a major side effect of Thrombocytopenia, anemia, shock

A

Rifampicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

What TB drug may have a major side effect of Oliguria or albuminuria

A

Rifampicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

What is the treatment for peripheral neuropathy caused by Isoniazid?

A

Give pyridoxine (Vit B6) 50–100 mg daily for treatment; it can also be given 10 mg daily for prevention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

What is the treatment for Arthralgia due to hyperuricemia due to pyrazinamide

A

Give aspirin or NSAID; if persistent, consider gout and request uric acid determination, manage accordingly or refer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

When do you schedule of sputum follow-up examinations for PTB on DS-TB regimen?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

When can you clear patient for work based on infectiousness?

A

After one week of uninterrupted treatment for clinically diagnosed TB cases.

After a negative follow-up SM for bacteriologically confirmed TB cases.

If patient wishes to return to work sooner, SM may be repeated (outside of the regular schedule) at least two weeks after treatment initiation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

How many months of interrupted treatment is required for designating patient as lost to follow up?

A

2 CONSECUTIVE months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

When do you label a patient as treatment failed

A

If positive sputum at the end of 5th month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

MDR-TB and RR-TB treatment shall be started within ____ from diagnosis.

A

seven days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

individuals who require further evaluation to assess eligibility for TB preventive treatment:

A

a. PLHIV aged 1 year and older (regardless of history of contact);
b. all household contacts of bacteriologically confirmed PTB;
c. children less than 5 years old who are household contacts of clinically diagnosed PTB;
d. close contacts of bacteriologically confirmed PTB (outside the household); and
e. other risk groups:
* patients receiving dialysis
* patients preparing for an organ or hematological transplantation
* patients initiating anti-tumor necrosis factor (TNF) treatment patients with silicosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

eligible groups for preventive TB regimen that do not require TST.

A

They may be offered TPT once active TB is ruled out:
a. PLHIV aged 1 year or older;
b. children less than 5 years old who are household contacts of bacteriologically
confirmed PTB; and
c. individuals aged 5 years and older with other TB risk factors (i.e. PLHIV, diabetes,
smoking, those with immune-suppressive medical conditions, malnourished,
with multiple TB cases in same household) and who are household contacts of
bacteriologically confirmed PTB.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

What are the treatment regimens for LTBI

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Most common cause of pleural effusion

A

LV failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

How do you diagnose hemothorax?

A

Pleural fluid/Serum Hct ratio >0.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

Recommended medication as both maintenance and reliever tx for asthma

A

ICS formoterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

Preferred OCS for pregnant women

A

prednisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

Clinical disorders associated with ARDS that causes direct lung injury

A

Pneumonia
Aspiration of gastric contents
Pulmonary contusion
Near drowning
Toxic inhalation injury

severe trauma, sepsis –> indirect lung injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

Goals for ARDS

TV
Plateau pressure
RR
Fio2
Spo2
pH
MAP

A

TV <=6 cc/kg
PP <= 30cm H2O
RR <= 35
Fio2 <=60%
Spo2 88-95%
pH >=7.3
MAP >=65

take note: lahat may equal sign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

In COPD patients with acute hyperbaric respi failure a ph of ____ is an indication for NIV

A

7.25-7.35

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

Cut off for cuff leak test (exhaled TV)

A

< 110 mL = positive leak test (no leak)

meaning a significant laryngeal edema is preventing a leak despite the cuff being deflated

basically negativity/positivity of cuff leak test is referring to the absence/presence of laryngeal edema NOT leak

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

In patients with active influenza or history of influenza, infection within 2 weeks of development of CAP, ____ / ____ should be added to CAP regimen

A

Vancomycin 15 mg/kg q8 OR Linezolid 600 mg q12

Think of MRSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

Predominant cell in gray hepatization in pneumonia

A

Neutrophil

Fibrin deposition is also abundant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

Predominant cell in resolution phase in pneumonia

A

Macrophage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

Most important risk factor for antibiotic resistant pneumonia

A

Prior antibiotic use in the past 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

Diagnostic threshold of ___ CFU is needed for diagnosis of pneumonia using endotracheal aspirate

A

10^6

10^3 for more distal sources

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

For hospitalized patients with CAP, when is a follow up CXR recommended?

A

4-6 weeks (Harrisons)

Based on PSMID 2020
We recommend posttreatment chest x-rays after a minimum of 6 to 8 weeks among patients with CAP to establish baseline and to exclude other conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

When do you expect the following ssx to resolve after pneumonia?

fever
chest pain and sputum production
cough and breathlesness

A

fever - 1 week
chest pain and sputum production - 1month
cough and breathlesness - 6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

What is the most potent risk factor for developing active TB?

A

HIV co-infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

What should you request if sputum microscopy is positive after the intensive phase?

A

Gene xpert

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

Level of anti trypsin to qualify for a1 antitrypsin augmentation therapy provided there is ABNORMAL CT findings

A

< 50 mg/dL or <11 uM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

Strong indications for starting corticosteroids in px with COPD

A

Hx of hospitalization for COPD exacerbation
> = 2 moderate exacerbation per year
Blood eosinophil > 300 cells/uL
Hx of concomitant asthm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

Which set of COPD px may undergo air travel without further assessment

A

Resting O2 >95%
6 minute walk oxygen >84%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

Roflumilast may only be considered in COPD px if

A

with FEV <50% predicted and if with chronic bronchitis

** additional info: Azith may be used in former smokers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

Which set of COPD px will likely benefit from lung volume reduction surgery

A

Upper lobe dominant emphysema and low exercise capacity post rehab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

Initial imaging of choice for initial evaluation of px with suspected ILD

A

HRCT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q

Apnea-Hypopnea index of someone with moderate OSA

A

15-29 events/hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

Px with silicosis are at risk of developing infection with these organisms (3)

A

MTB
atypical mycobacteria
fungi

due to alveolar macrophage dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

Phase of pneumonia that corresponds with the successful containment of the infection and improvement in gas exchange

A

Gray hepatization

no new erythrocytes are extravasating, and those already present have been lysed and degraded. The neutrophil is the predominant cell, fibrin deposition is abundant, and bacteria have disappeared

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

Pneumonia pattern most common in nosocomial pneumonias

A

A bronchopneumonia pattern is most common in nosocomial pneumonias, whereas a lobar pattern is more common inbacterial CAP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

Possible pneumonia pathogens for those with dementia, stroke or with dec level of consciousness

A

Oral anaerobes
G- bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

Possible pneumonia pathogens for those with structural lung disease

A

P. aeruginosa
B. cepacia
S. aureus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

Define good catch sputum sample

A

(To be suitable, a sputum sample must have >25 neutrophils and <10 squamous epithelial cells per low-power field.)

No equal sign!

The sensitivity and specificity of the sputum Gram’s stain and culture are highly variable. Even in cases of proven bacteremic pneumococcal pneumonia, the yield of positive cultures
from sputum is ≤50%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
130
Q

Most common isolate in blood cultures of px with pneumonia

A

S. pneumoniae

The yield from blood cultures, even when samples are collected before antibiotic therapy, is disappointingly low. Only 5–14% of cultures from hospitalized CAP patients are positive, and
the most common pathogen is S. pneumoniae.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
131
Q

What variables constitute CURB 65

A

confusion (C);
urea>7 mmol/L (U);
respiratory rate ≥30/min (R);
SBP ≤90 mmHg OR DBP ≤60 mmHg (B)
an age of ≥65 years.

With a score of 1 or 2, the patient should be hospitalized unless the score is entirely or in part attributable to an age of ≥65 years

Among patients with scores of ≥3, mortality rates are 22% overall; these patients may require ICU admission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
132
Q

According to Harrisons, What antibiotics may be given to outpx with pneumonia

A

Take note amox only if no comorbs but if with co morbs, need to be coamox

FQ only for those with comorbs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
133
Q

Which of the 2 (PPSV 23 vs PCV13) produces T-cell–dependent antigens, resulting in long-term immunologic memory.

A

PCV13 produces T-cell–dependent
antigens, resulting in long-term immunologic memory.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
134
Q

Three factors are critical in the pathogenesis of VAP:

A

colonization of the oropharynx with pathogenic microorganisms
aspiration of these organisms from the oropharynx into the lower respiratory tract
compromise of normal host defense mechanisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
135
Q

The most obvious risk factor for VAP

A

endotracheal tube, which bypasses the normal mechanical factors preventing aspiration

Because endotracheal intubation is a risk factor for VAP, the most important preventive intervention is to avoid intubation or minimize
its duration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
136
Q

major risk factor for infection with MRSA and ESBL-positive strains.

A

Frequent use of β-lactam drugs, especially cephalosporins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
137
Q

The major difference from CAP is the markedly lower incidence of atypical pathogens in VAP; the exception is ______

A

Legionella

can be a nosocomial pathogen, especially with local epidemics due to breakdowns in the treatment of potable water in the hospital.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
138
Q

According to Harrisons, What antibiotics may be given to in px with VAP/HAP

A

Refer to table

7- or 8-day course of therapy is just as effective as a 2-week course and is associated with less frequent emergence of antibioticresistant
strains.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
139
Q

The only pathogens that may be more common in the non-VAP population are ____ because of a greater risk of macroaspiration and the lower oxygen tensions in the lower respiratory tract of these patients.

A

anaerobes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
140
Q

In COPD patients
PaO2 remains normal or near normal until FEV1 decreases to about _ % of predicted
PCO2 elevation is expected when FEV1
decreases to less than _ % of predicted

A

50%
25%

hence mauuna o2 bumaba

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
141
Q

three interventions that have been demonstrated to improve survival of patients with COPD

A

smoking cessation
oxygen therapy in chronically hypoxemic patients
lung volume reduction surgery (LVRS) in selected patients with emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
142
Q

Thoracentesis is required for the which set of patients with heart failure and pleural effusion

A
  • Unilateral
  • Bilateral but not comparable in size
  • Presence of fever
  • Presence of pleuritic chest pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
143
Q

most common cause of secondary
pneumothorax

A

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
144
Q

Rapid recovery and liberation from mechanical
ventilation is expected for most ARDS cases during days 7-21. Which phase of ARDS is this?

A

Proliferative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
144
Q

Treatment for aerophagia in px using CPAP

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
144
Q

most common symptom in pulmonary
embolism

A

Unexplained breathlessness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
145
Q

Treatment for difficulty exhaling in px using CPAP

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
146
Q

Which pattern of interstitial lung disease is most
commonly seen in patients with rheumatoid arthritis?

A

Non-specific interstitial pneumonia

UIP if IPF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
147
Q

What is the most common underlying cause of
blood-tinged sputum and small volume
hemoptysis?

A

Viral bronchitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
148
Q

Average diurnal PEF variability in asthma is > ___%

A

10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
149
Q

FEV that will indicate good response after the initial management of an acute exacerbation of asthma?

A

FEV1 or PEF 60-80% of personal best

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
150
Q

Test that may be done to test for compliance to ICS

A

FeNO

Elevated levels (>35–40 ppb) in untreated patients are indicative of eosinophilic inflammation.

Levels >20–25 ppb in patients with severe asthma on moderate- to high-dose ICS indicate either poor adherence or persistent type 2 inflammation despite therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
151
Q

How long should you hold SABA before performing reversibility testing in asthma

A

4 hrs

LABA-ICS –> 12 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
152
Q

most typical pathophysiologic finding in COPD?

A

Persistent reduction in forced expiratory flow rates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
153
Q

As part of diagnosis and assessment of patients with COPD, arterial blood gases should be assessed when the peripheral oxygen saturation is less than ___

A

92%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
154
Q

Severity of COPD if FEV1/FVC is 50 to <80 % of predicted

A

Moderate

Mild >=80
Moderate 50- <80%
Severe 30-< 50%
Very Severe < 30%

155
Q

Barotrauma and hyperventilation are potential disadvantages of what form of mechanical ventilation?

A

AC mode

156
Q

how long (__ hrs /day) is long term oxygen therapy for COPD?

A

At least 15h/day

157
Q

second most common site of extrapulmonary tuberculosis is

A

pleura

158
Q

What is the most common cause of secondary pneumothorax?

A

COPD

159
Q

Description of mmrc 2 in copd

A

“I walk slower than people of the same age on the level because of breathlessness, or I have to stop for breath when walking at my own pace on the level.”

160
Q

Oral anticoagulant does not need “bridging” with parenteral anticoagulation prior to initiation as treatment for venous thromboembolism

A

apixaban

161
Q

Many patients with ARDS who will not enter the fibrotic phase may recover lung function after how may weeks from the initial pulmonary injury?

A

3-4 weeks

162
Q

in patients with CAP, Radiographic abnormalities are expected to resolve in how mnay weeks

A

4-12weeks

163
Q

Treatment of choice for chylothorax

A

chest tube insertion + octreotide

164
Q

expected pulmonary function test among patients with asbestosis

A

Restrictive pattern with a decrease in both lung volumes and diffusing capacity

165
Q

_____bronchiectasis is described as a classic finding on chest imaging in ABPA but is not necessary for making a diagnosis

A

Central

166
Q

Based on 2024 GINA guidelines, what is the only ICS-LABA that may be used as antiinflammatory relieved

A

ICS-formoterol

167
Q

Based on 2024 GINA guidelines consider stepping down when symtoms of asthma are well controlled and lung function are stable for at least __ months

A

3

168
Q

the preferred mode of ventilation for patients in whom it is desirable to regulate peak airway pressures, such as those with preexisting barotrauma, and for post– thoracic surgery patients, in whom the shear forces across a fresh suture line should be limited

A

PCV

169
Q

In pneumomediastinum _________ sign, is a crunching or clicking noise synchronous with the heartbeat and is best heard in the left lateral decubitus position

A

Hamman’s

170
Q

Hallmark of alveolar hypoventilation

A

High PCO2 with normal pH

171
Q

3 tumors that cause 75% of all malignant pleural effusions are

A

lung CA, breast CA and lymphoma

172
Q

Secondary TB has predilection to which segment of the lungs

A

apical and posterior segments of the upper lobes

173
Q

Most commonly involved lung zones in primary TB

A

middle and lower lung zones

174
Q

Classic finding in pulmonary ARTERIAL hypertension

A

isolated reduction in DLCO

175
Q

2 main goals of COPD therapy

A

The two main goals of therapy are to provide symptomatic relief (reduce respiratory symptoms, improve exercise tolerance, improve health status) and reduce future risk (prevent disease progression, prevent and treat exacerbations, and reduce mortality)

176
Q

Adventitious lung sound that is a manifestation of obstruction of medium-sized airways, most often with secretions

A

Rhonchi

Crackles, or rales, are commonly a sign of alveolar disease.

177
Q

Cyanosis is seen in hypoxemic respiratory disorders that result in >__ g of deoxygenated hemoglobin/dL

A

Cyanosis is seen in hypoxemic respiratory disorders that result in >5 g of deoxygenated hemoglobin/dL

178
Q

A total lung capacity <__% of the patient’s predicted value defines restrictive pathophysiology

A

80

179
Q

The excursion between full and minimal lung inflation is called ______ and is readily seen to be the difference between volumes at two unrelated stiffness extremes—one determined by the lung (TLC) and the other by the chest wall or airways (RV).

A

vital capacity

180
Q

Functional residual capacity constitutes which lung volumes

A

ERV + RV

181
Q

What airway pathology can present with DLCO > 100%

A
182
Q

What airway pathology can present with TLC > 100%

A
183
Q

The total amount of air exhaled is the ___

A

FVC

184
Q

Diseases that present with scooping of the flow volume loop

A

In diseases that cause lower airway obstruction, such as asthma and emphysema, flows decrease more rapidly with declining lung volumes, leading to a characteristic scooping of the flow-volume loop

185
Q

hallmark of asthma

A

Airway hyperresponsiveness is a hallmark of asthma

186
Q

Structural abnormalities associated with airway hyperresponsiveness in asthma

A

In asthma, airway wall thickness is associated with disease severity and duration. This thickening, which may result from a combination of smooth-muscle hypertrophy and hyperplasia, subEPIthelial collagen deposition, airway edema, and mucosal inflammation, can result in a tendency for the airway to narrow disproportionately in response to stimuli that elicit increased airway muscle tension

187
Q

IL-___ induces B-cell isotype switching to production of IgE

A

IL-4 induces B-cell isotype switching to production of IgE

188
Q

IL-__ induces airway hyperresponsiveness, mucus hypersecretion, and goblet cell metaplasia

A

IL-13 induces airway hyperresponsiveness, mucus hypersecretion, and goblet cell metaplasia

189
Q

IL-__me has a critical role in regulating eosinophils. It controls formation, recruitment, and survival of these cells

A

. IL-5 has a critical role in regulating eosinophils. It controls formation, recruitment, and survival of these cells

190
Q

Goals of asthma therapy

A
191
Q

Regular use of beta agonists has been associated with tachyphylaxis of the bronchoprotective effect and possible increased airway reactivity. This may be more common in patients with a polymorphism at the ___th amino acid position of the β2 -receptor.

A

Regular use has been associated with tachyphylaxis of the bronchoprotective effect and possible increased airway reactivity. This may be more common in patients with a polymorphism at the 16th amino acid position of the β2 -receptor.

Frequent short-acting β-2 agonist use has been associated with increased asthma mortality resulting in decreased enthusiasm for use in isolation without inhaled corticosteroidsa

192
Q

Examples of ultra long LABA

A

These agents (indacaterol, olodaterol, and vilanterol) have a 24-h effect. They are only used in combination with ICSs in the treatment of asthma.

193
Q

pneumocystis pneumonia prophylaxis should be administered for those asthmatic px maintained on a daily prednisone dose of ≥___

A

20 mg

194
Q

MOA of montelukast and zafirlukast

A

leukotriene receptor antagonist
inhibits cysteinyl leukotriene type-1 (CysLT1)
moderately effective in asthma

Zileuton - 5 LOX inhibitor

195
Q

T/F
Patients with aspirin exacerbated respiratory dse should avoid all NSAIDs

A

These patients should avoid inhibitors of cyclooxygenase-1, (aspirin and NSAIDs) but can generally tolerate inhibitors of cyclooxygenase-2 and acetaminophen

They should be treated with leukotriene modifiers.

Aspirin desensitization can be undertaken to decrease upper respiratory symptoms and to allow chronic administration of aspirin or NSAIDs for those that require it.

Dupilumab and the IL-5–active biologics appear to be particularly helpful and appear to be superseding aspirin desensitization in management except when chronic administration of aspirin or NSAIDs is required for another therapeutic indication.

196
Q

ACO is common in which subset of population

A

Elderly and smokers

197
Q

SABA overuse based from GINA 2023 is defined as

A

> = 3 200 dose canisters per yr

mortality is inc if >=1 canister per month

198
Q

Based on GINA 2023 when should lung function test be repeated after dx of asthma

A

3-6 months

199
Q

First step before initiating asthma tx

A

Record evidence and dx of asthma

200
Q

Doses of inhaled corticosteroids for asthma

A
201
Q

Add on therapy for STEP 5 asthma control based on GINA 2023

A
202
Q

How often should patients with asthma be reviewed?

A

1-3 months after treatment and every 3-12 months after that
BUT in pregnancy asthma should be reviewed every 4-6 weeks

203
Q

What should be given in asthma px during surgery if they are on long term high dose ICS or >2 weeks OCS in the past 6 months?

A

Intraop hydrocortisone

204
Q

T/F OCS in asthma should always be tapered

A

False

No need for tapering if < 2 weeks

Additional note: pred should be given in AM

205
Q

Target O2 sat in asthmatic px as per GINA 2023

A

93-95%

206
Q

Management of asthma exacerbations in primary care

A
207
Q

When should you follow up px with asthma after any exacerbation?

A

2-7 days

208
Q

CXR findings in hypersensitivity pneumonitis

A

Chest x-ray findings in HP are nonspecific and can even lack any discernible abnormalities. In cases of acute and subacute HP, findings may be transient and can include ill-defined micronodular opacities or hazy ground-glass airspace opacities

209
Q

Stronges predictor for hypersensitivity pneumonitis

A

Although not meant as a set of validated diagnostic criteria, a clinical prediction rule for predicting the presence of HP has been published by the HP Study Group. They identified six statistically significant predictors for HP, the strongest of which was exposure to an antigen known to cause HP

210
Q

Mainstay of tx for hypersensitivity pneumonitis

A

antigen avoidance

Although glucocorticoids do not change the long-term outcome in these patients, they can accelerate the resolution of symptoms. While there is significant variability in the approach to glucocorticoid therapy by individual clinicians, prednisone therapy can be initiated at 0.5–1 mg/kg of ideal body weight per day (not to exceed 60 mg/d or alternative glucocorticoid equivalent) over a duration of 1–2 weeks, followed by a taper over the next 2–6 weeks.

211
Q

Diagnostic criteria for acute eosinophilic pneumonia

A
212
Q

Loffler syndrome is associated with which parasites

A

Loffler syndrome refers to transient pulmonary infiltrates with eosinophilia that occurs in response to passage of helminthic larvae through the lungs, most commonly larvae of Ascaris species (roundworm). Symptoms are generally self-limited and may include dyspnea, cough, wheeze, and hemoptysis. Loffler syndrome may also occur in response to hookworm infection with Ancylostoma duodenale or Necator americanus.

213
Q

classic finding on chest imaging in ABPA (ALLERGIC BRONCHOPULMONARY
ASPERGILLOSIS)

A

Central bronchiectasis is described as a classic finding on chest imaging in ABPA but is
not necessary for making a diagnosis. Other possible findings on chest
imaging include patchy infiltrates and evidence of mucus impaction

214
Q

Treatment for ABPA

A

Systemic glucocorticoids may be used in the treatment of ABPA that is persistently symptomatic despite the use of inhaled therapies for asthma. Courses of glucocorticoids should be tapered over 3–6 months, and their use must be balanced against the risks of prolonged steroid therapy.

Antifungal agents such as itraconazole and voriconazole given over a 4-month course reduce the antigenic stimulus in ABPA and may therefore modulate disease activity in selected patients. Newer azole agents may be used as well.

The use of monoclonal antibody against IgE (omalizumab) has been described in treating severe ABPA, particularly in individuals with ABPA as a complication of cystic fibrosis.

Other monoclonal antibodies used in severe eosinophilic asthma, such as those targeting IL-5 (or its receptor) or targeting IL-4-receptor-alpha, may be considered as well in refractory cases

215
Q

EOSINOPHILIC GRANULOMATOSIS WITH
POLYANGIITIS (EGPA) is AKA as

A

allergic angiitis granulomatosis or Churg-Strauss
syndrome

216
Q

Hallmark finding of EGPA

A

Systemic eosinophilia is the hallmark laboratory finding in patients with EGPA and reflects the likely pathogenic role that the eosinophil plays in this disease.

Eosinophilia >10% is one of the defining features of this illness and may be as high as 75% of the peripheral white blood cell count.

It is present at the time of diagnosis in >80% of patients, but may respond quickly (often within 24 h) to initiation of systemic corticosteroid therapy.

217
Q

most common CT findings of EGPA

A

The most common CT findings include bilateral ground-glass opacity and airspace consolidation that is predominantly subpleural. Other CT findings include bronchial wall thickening, hyperinflation, interlobular septal thickening, lymph node enlargement, and pericardial and pleural effusions.

218
Q

Involvement of these systems in EGPA most often portend a poor prognosis

A

Myocardial, GI, and renal involvement most often portend a poor prognosis.

219
Q

Light’s criteria

A
220
Q

most common cause of an exudative pleural effusion

A

In many parts of the world, the most common cause of an exudative pleural effusion is tuberculosis (TB)

2nd- malignancy

The diagnosis is established by demonstrating high levels of TB markers in the pleural fluid (adenosine deaminase >40 IU/L or interferon γ >140 pg/mL).

221
Q

If the pleural hemorrhage exceeds ___ mL/h, consideration should be given to angiographic coil embolization, thoracoscopy, or thoracotomy

A

200

222
Q

The major risk factors for OSA are

A

The major risk factors for OSA are obesity, male sex, and older age

A 10% weight gain is associated with a >30% increase in AHI.

Even modest weight loss or weight gain can influence the risk and severity of OSA. However, the absence of obesity does not exclude this diagnosis

223
Q

A partially obstructed breath, typically within a hypopnea or RERA, identified by a flattened or “scooped-out” inspiratory flow shape

A

Flow limited breath

224
Q

How do you classify OSA

A
225
Q

Average effect of CPAPon BP

A

Although the overall impact of CPAP on blood pressure levels is relatively modest (averaging 2–4 mmHg), larger improvements are observed among patients who have a high AHI, report daytime sleepiness, or have resistant hypertension

226
Q

Lifestyle modifications for OSA

A

As appropriate, treatment should aim to reduce weight; optimize sleep duration (7–9 h); regulate sleep schedules (with similar bedtimes and wake times across the week); encourage the patient to avoid sleeping in the supine position; treat nasal allergies; increase physical activity; eliminate alcohol ingestion (which impairs pharyngeal muscle activity) within 3 h of bedtime; and minimize use of opiate medications. Sedative hypnotic medications have inconsistent effects on OSA but should be avoided in most patients with moderate to severe OSA

227
Q

CPAP side effects and their treatments

A
228
Q

Most commonly performed surgery for OSA

A

Uvulopalatopharyngoplasty (removal of the uvula and the margin of the soft palate) is the most commonly performed surgery for OSA and, although results vary greatly, is generally less successful than treatment with oral appliances.

229
Q

Cheyne-Stokes breathing is treated by

A

optimizing therapy for heart failure

230
Q

Central sleep apnea (CSA) is caused by

A

CSA is often caused by an increased sensitivity to Pco2 , which leads to an unstable breathing pattern that manifests as hyperventilation alternating with apnea

231
Q

physiologic marker of COPD

A

Airflow obstruction, the physiologic marker of COPD, can result from airway disease and/or emphysema.

232
Q

prevailing mechanism for the development of emphysema

A

The elastase:antielastase hypothesis remains a prevailing mechanism for the development of emphysema

233
Q

T/F
The absolute annual loss in FEV1 tends to be highest in mild COPD and lowest in very severe COPD

A

True

234
Q

paradoxical inward movement of the rib cage with inspiration is called _____ sign

A

Some patients with advanced disease have paradoxical inward movement of the rib cage with inspiration (Hoover’s sign), the result of alteration of the vector of diaphragmatic contraction on the rib cage due to chronic hyperinflation

235
Q

Management of COPD based on Harrisons

A
236
Q

Based on Harrisons, when should you consider LAMA + LABA+ ICS in px with COPD

A

The main role of ICS is to reduce exacerbations. In population studies, patients with an eosinophil count of <100 cells per microliter do not benefit, while benefit increases as eosinophil counts rise above 100

A trial of ICS should be considered in patients with frequent exacerbations, defined as two or more per year or in patients hospitalized with one exacerbation

** based on GOLD, dpaat eoino >300

237
Q

Recommended vaccines for COPD px based on Harrisons

A

Patients with COPD should receive the influenza vaccine annually. Pneumococcal vaccines and vaccination for Bordetella pertussis are recommended.

B-P-I

237
Q

T/F

Based on CPG 2023, LABA + LAMA is preferred over LAMA or LABA monotherapy among stable COPD patients in the primary care setting with FEV1<80% or mMRC≥2

A

True
Among stable COPD patients in the primary care setting with FEV1<80% or mMRC≥2* and are not in exacerbation, we recommend the use of LABA/LAMA combination therapy over LAMA or LABA monotherapy

238
Q

T/F

Based on CPG 2023, ICS may be given in COPD px with increased risk for exacerbations and absence of concurrent respiratory infection

A

True

Among stable COPD patients in the primary care setting with FEV1<80% or mMRC≥2* with increased risk for exacerbations and absence of concurrent respiratory infection**, we recommend the use of inhaled corticosteroids in combination with inhaled long-acting bronchodilators

BUT if GOLD A lang

Among stable COPD patients in the primary care setting with FEV1≥80% or mmRC<2* and are not in exacerbation, we suggest the use of LAMA monotherapy over LABA monotherapy or LABA/LAMA combination therapy

239
Q

T/F
Based on CPG 2023, adding methylxanthines to LABA in COPD px has no benefit

A

False

Among stable COPD patients in the primary care setting, we recommend against adding oral methylxanthines to inhaled long-acting bronchodilator

240
Q

Recommended bronchodilator in COPDIAE

A

Among patients with COPD,recommend the use of SABA+SAMA (combination therapy) in the management of acute exacerbation.

In situations where SABA+SAMA is not readily available, SABA may be used

241
Q

Based on CPG 2023, when is initiation of antibiotics recommended in px with COPD

A

Among outpatients with COPD, we recommend initiation of oral antibiotics in the presence of at least two of the following symptoms: increased dyspnea, increased frequency of cough, increased sputum volume or purulence

242
Q

T/F

As per CPG 2023, oral steroids are recommended among COPD patients in exacerbation with worsening symptoms and not responding to bronchodilators

A

True

Among COPD patients in exacerbation with worsening symptoms and not responding to bronchodilators, we recommend the use of short course* oral steroids in the primary care setting

short course = 5 days of 30 mg prednisolone

243
Q

As per CPG 2023, when should we refer COPD px to higher level of care

A

Among COPD patients managed at the primary level, we recommend referral of any of the following conditions that are associated with higher risk of mortality to higher level of care: presence of uncontrolled diabetes or cardiovascular disease, previous hospitalization for acute exacerbation within the past year, hospital readmission within 30 days, and use of long-term oxygen therapy

244
Q

CXR findings of past exposure to asbestos

A

Past exposure to asbestos is specifically indicated by pleural plaques on chest radiographs, which are characterized by either thickening or calcification along the parietal pleura, particularly along the lower lung fields, the diaphragm, and the cardiac border. Without additional manifestations, pleural plaques imply only exposure, not pulmonary impairment

245
Q

PFT of px with asbestosis

A

Pulmonary function testing in asbestosis reveals a restrictive pattern with a decrease in both lung volumes and diffusing capacity. There may also be evidence of mild airflow obstruction (due to peribronchiolar fibrosis).

246
Q

Difference between mesothelioma and lung CA

A

Mesothelioma, both pleural and peritoneal, are also associated with asbestos exposure. In contrast to lung cancers, these tumors do not appear to be associated with smoking.

Relatively shortterm asbestos exposures of ≤1–2 years, occurring up to 40 years in the past, have been associated with the development of mesotheliomas

246
Q

Definition of complicated silicosis and progressive massive fibrosis

A

Calcification of hilar nodes may occur in as many as 20% of cases and produces a characteristic “eggshell” pattern. Silicotic nodules may be identified more readily by HRCT. The nodular fibrosis may be progressive in the absence of further exposure, with coalescence and formation of nonsegmental conglomerates of irregular masses >1 cm in diameter (complicated silicosis).

**same cut off of >=1cm for complicated coal workers pneumoconiosis

These masses can become quite large, and when this occurs, the term progressive massive fibrosis (PMF) is applied

247
Q

Silicosis is associated with greater risk of acquiring lung infection particularly caused by these agents

A

Because silica causes alveolar macrophage dysfunction, patients with silicosis are at greater risk of acquiring lung infections that involve these cells as a primary defense (Mycobacterium tuberculosis, atypical mycobacteria, and fungi).

248
Q

Usual location of complicated coal workers pneumoconiosis

A

Complicated CWP is manifested by the appearance on the chest radiograph of nodules ≥1 cm in diameter generally confined to the upper half of the lungs

249
Q

Diagnosis of chronic beryllium disease

A

Fiberoptic bronchoscopy with transbronchial lung biopsy usually is required to make the diagnosis of CBD.

Others:
The test that usually provides this evidence is the beryllium lymphocyte proliferation test (BeLPT).

250
Q

This condition results from exposure to moldy hay containing spores of thermophilic actinomycetes that produce a hypersensitivity pneumonitis

A

Farmer’s lung

A patient with acute farmer’s lung presents 4–8 h after exposure with fever, chills, malaise, cough, and dyspnea WITHOUT wheezing.

251
Q

ILDthat will present with Bilateral subpleural reticular changes most prominent in lower, posterior lung zones. Traction bronchiectasis and honeycombing common. Classic usual interstitial pneumonia (UIP) pattern is considered diagnostic

A

IPF

252
Q

ILD that will present with Peripheral subpleural ground glass and reticular patterns. Traction bronchiectasis is common, but honeycombing is rare

A

Non specific interstitial pneumonia

Idiopathic NSIP is often treated with oral steroids (prednisone), cytotoxic agents (mycophenolate, azathioprine, and cyclophosphamide), or biologics (rituximab)

253
Q

ILD that will present as Respiratory bronchiolitis with adjacent inflammatory and fibrosing changes. Pigment-laden macrophages

A

Respiratory bronchiolitis associated ILD

254
Q

Most common complaint in px with ILD

A

Progressive dyspnea, most frequently noted with exertion, is the most common complaint in patients presenting with an ILD

255
Q

PFT of px with ILD

A

Most forms of ILD will eventually result in a restrictive deficit on pulmonary function testing. A restrictive deficit is typified by a reduced total lung capacity (TLC) and symmetrically reduced measures of forced expiratory volume in 1 s (FEV1 ) and forced vital capacity (FVC). A reduction in the diffusing capacity of the lung for carbon monoxide (DlCO) is also common and may precede a reduction in lung volumes; however, there is more measurement variability in DlCO measurement and the test is less specific for ILD

256
Q

standard of care in the initial evaluation of a patient with a suspected ILD.

A

High-resolution CT (HRCT) chest imaging is now considered to be standard of care in the initial evaluation of a patient with a suspected ILD.

257
Q

tandard of care for patients with advanced and rapidly progressive ILDs

A

lung transplantation remains the standard of care for patients with advanced and rapidly progressive ILDs.

257
Q

most common ILD of unknown cause

A

IPF is the most common ILD of unknown cause

258
Q

Most common HRCT finding of cyrptogenic organizing pneumonia

A

The most common imaging findings include patchy, sometimes migratory, subpleural consolidative opacities often with associated ground-glass opacities.

Peribronchiolar or perilobar opacities can be present, and sometimes a rim of subpleural sparing (often referred to as a REVERSED HALO or ATOLL SIGN) can be seen, which can aid in the diagnosis

Corticosteroids can result in substantial clinical improvement in many patients but usually need to be continued for at least 6 months as relapse rates are high

259
Q

most common pulmonary manifestation of systemic sclerosis

A

ILD

Cyclophosphamide has a modest benefit in preservation of lung function and is associated with significant toxicity. Mycophenolate has recently been shown to have similar efficacy and improved tolerability. Clinical trials have demonstrated that antifibrotic therapy (e.g., nintedanib) may benefit patients with systemic sclerosis associated pulmonary fibrosis

260
Q

The most common imaging pattern of ILD in patients with RA

A

The most common imaging pattern of ILD in patients with RA is a UIP pattern, although NSIP patterns are not uncommon

261
Q

Characteristics of anti-synthetase syndrome

A

The anti-synthetase syndrome is characterized by positive anti-synthetase antibodies, myositis, fever, Raynaud’s phenomenon, mechanic’s hands, arthritis, and progressive ILD

Immunosuppressive (e.g., prednisone) and cytotoxic (e.g., mycophenolate, azathioprine, cyclophosphamide, and calcineurin inhibitors) agents are often used in patients with progressive ILD

262
Q

The most infectious TB patients

A

The most infectious patients have cavitary pulmonary disease or, much less commonly, laryngeal TB and produce sputum containing as many as 105 –107 AFB/mL

additional note:
Because persons with both HIV infection and TB are less likely to have cavitations, they may be less infectious than persons without HIV co-infection

263
Q

T/F

Those with culture-negative pulmonary TB and extrapulmonary TB are essentially noninfectious

A

True

263
Q

Most commonly involved lung zones in primary TB

A

Because most inspired air is distributed to the middle and lower lung zones, these areas are most commonly involved in primary TB.

264
Q

The lesion forming after initial infection is called __________ is usually peripheral and accompanied by transient hilar or paratracheal lymphadenopathy, which may or may not be visible on standard chest radiography (CXR

A

The lesion forming after initial infection (Ghon focus) is usually peripheral and accompanied by transient hilar or paratracheal lymphadenopathy, which may or may not be visible on standard chest radiography (CXR)

The Ghon focus, with or without overlying pleural reaction, thickening, and regional lymphadenopathy, is referred to as the Ghon complex

265
Q

Most commonly involved lung segments in post primary or adult type PTB dse

A

It is usually localized to the apical and posterior segments of the upper lobes, where the substantially higher mean oxygen tension (compared with that in the lower zones) favors mycobacterial growth.

266
Q

Hemoptysis in PTB, however, may also result from rupture of a dilated vessel in a cavity AKA _______ aneurysm) or from aspergilloma formation in an old cavity

A

Hemoptysis, however, may also result from rupture of a dilated vessel in a cavity (Rasmussen’s aneurysm) or from aspergilloma formation in an old cavity

267
Q

Characteristic pleural uppfluid in px with TB pleuritis

A

The fluid is straw-colored and at times hemorrhagic; it is an exudate with a protein concentration >50% of that in serum (usually ~4–6 g/dL), a normal to low glucose concentration, a pH of ~7.3 (occasionally <7.2), and detectable white blood cells (usually 500–6000/μL). Neutrophils may predominate in the early stage, but lymphocyte predominance is the typical finding later

268
Q

Most commonly involved parts of the spine in px with Pott’s dse

A

Whereas the upper thoracic spine is the most common site of spinal TB in children, the lower thoracic and upper lumbar vertebrae are usually affected in adults

268
Q

How long should steroids be used in CNS TB as per WHO guidelines

A

The WHO now recommends that adjuvant glucocorticoid therapy with either dexamethasone or prednisolone, tapered over 6–8 weeks, should be used in CNS TB.

269
Q

preferred initial diagnostic option for pulmonary TB

A

The Xpert MTB/RIF assay is the preferred initial diagnostic option for pulmonary TB ensuring a sensitivity of 81% and a specificity of 98%, and therapy should be started on the basis of a positive result because treatment delays may be fatal. A negative Xpert MTB/RIF result, however, does not exclude a diagnosis of TB. Culture remains the gold standard.

270
Q

Management for TB IRIS

A

IRIS can result in serious neurologic complications or death in patients with CNS TB. Therefore, ART should not be initiated during the first 8 weeks of TB treatment in patients with TB meningitis.

BUUUUT
ART should be started within the first 2 weeks of TB treatment for profoundly immunosuppressed patients with CD4+ T-cell counts of <50/μL.

Glucocorticoids have been used for severe paradoxical reactions; prednisolone given for 4 weeks at a low dosage (1.5 mg/kg per day for 2 weeks and half that dose for the remaining 2 weeks) has reduced the need for hospitalization and therapeutic procedures and has hastened alleviation of symptoms, as reflected by Karnofsky performance scores, quality-of-life assessments, radiographic response, and C-reactive protein levels

271
Q

Genes associated with INH resistance

A

katG and inhA

272
Q

Gene associated with Rifampicin resistance

A

rpo B

273
Q

TB regimen dosing

A
274
Q

Groupings of second line TB drugs

A

Group A drugs include three classes of oral agents: the fluoroquinolones levofloxacin and moxifloxacin; the oxazolidinone linezolid; and the recently introduced diarylquinoline bedaquiline, which was granted accelerated approval by the FDA in late 2012.
Group B drugs include two other oral agents: clofazimine and cycloserine (or its analogue terizidone).
Group C drugs include the nitroimidazole delamanid; imipenemcilastatin or meropenem; the injectable aminoglycosides amikacin and streptomycin

275
Q

With the recommended 6-month standard first-line regimen, >80% of drug-susceptible TB patients will have negative sputum cultures at the end of the

A

second month of treatment.

By the end of the third month, the sputum of virtually all patients should be culture negative

treatment failure should be suspected when a patient’s cultures (or sputum smears, when cultures are not available) remain positive after 3 months of treatment

276
Q

The most common adverse reaction of significance among people treated for drug-susceptible TB is

A

The most common adverse reaction of significance among people treated for drug-susceptible TB is hepatitis

277
Q

Gene involved in pyrazinamide and ethambutol resistance

A

pyrazinamide in the pncA gene (up to 98%), that to ethambutol in the embB gene (50–65%),

278
Q

Management for MDR/RR TB

A

two main approaches are now recommended by the WHO to treat MDR/RR-TB: (1) an individualized longer regimen of 18–20 months’ duration (or 15-17 months after culture conversion) consisting of an optimal combination of oral drugs chosen according to a rational approach and using the WHO priority grouping of medicines; and (2) a shorter, all-oral, bedaquiline-containing regimen of 9–12 months’ duration.

279
Q

Criteria for Offering a Shorter All-Oral Regimen (9−11 Months) to Patients with Confirmed Multidrug- or Rifampin-Resistant (MDR/RR) Tuberculosis (TB)

A
280
Q

Cutoff tuberculin test for organ transplant recipient

A

> = 5 mm

281
Q

Cutoff tuberculin test for Persons with fibrotic lesions consistent with old TB on chest radiography

A

> = 5 mm

282
Q

Cutoff tuberculin test for Recent immigrants (≤5 years) from high-prevalence countries

A

> =10mm

283
Q

Cutoff tuberculin test for injection drug users

A

> =10mm

284
Q

Duration for Isoniazid for TB preventive tx

A

most widely used has been that based on isoniazid alone at a daily dose of 5 mg/kg (up to 300 mg/d) for 9 months. On the basis of cost–benefit analyses and concerns about feasibility, a 6-month period of treatment at the same dose is considered adequate by the WHO.

285
Q

Tuberculosis Preventive Tx Regimen

A
286
Q

What constitutes SOFA score

A
287
Q

What constitutes APACHE score

A
288
Q

The neuromuscular blocking agent ___________ is occasionally used to facilitate mechanical ventilation in patients with profound ventilator dyssynchrony despite optimal sedation, particularly in the setting of severe ARDS. Use of these agents may result in prolonged weakness—a myopathy known as the postparalytic syndrome.

A

cisatracurium

289
Q

T/F All ICU px without contraindication to anticoag should receive DVT prophylaxis

A

True
All ICU patients are at high risk for this complication because of their predilection for immobility. Therefore, all should receive some form of prophylaxis against DVT if feasible

290
Q

T/F Prophylaxis against stress ulcers is necessary for all ICU patients

A

False
Prophylaxis against stress ulcers is not necessary for all ICU patients.

It should only be administered to high-risk patients, such as those with coagulopathy or respiratory failure requiring mechanical ventilation

291
Q

When parenteral feeding is necessary to supplement enteral nutrition, delaying this intervention until day ___ in the ICU results in better recovery and fewer ICU-related complications.

A

When parenteral feeding is necessary to supplement enteral nutrition, delaying this intervention until day 8 in the ICU results in better recovery and fewer ICU-related complications.

292
Q

Studies have shown that most ICU patients are anemic as a result of

A

chronic inflammation

293
Q

Diagnostic criteria for ARDS

A
294
Q

key difference between volume control and PCV

A

The key difference between volume control and PCV is that an inspiratory (or “driving”) pressure is set instead of a tidal volume in PCV; thus, every time the ventilator delivers a breath, it raises the airway pressure to the set amount above PEEP until inspiratory flow decreases below a set threshold, therefore ending inhalation. Thus, the resulting tidal volume will vary depending on the compliance of the lung

PCV is often used to limit peak airway and lung distending (plateau) pressures in situations where high pressure can cause harm, such as in ARDS or after thoracic surgery with fresh suture lines in the airways or lung parenchyma

295
Q

Difference betwen PSV and PCV

A

no mandated ventilation, or set mechanical respiratory rate, on PSV, and ventilator support is entirely patient triggered and controlled.

296
Q

Key Features of different MV settings

A
297
Q

Common contraindications to NIV

A
298
Q

Most hypercapnia cases in the ICU is due to

A

most hypercapnia is due to inadequate alveolar ventilation (VA) from an increase in the fraction of dead space (VD)

Hypercapnia in the context of low tidal volume (6 mL/kg) ventilation for ARDS often causes acute respiratory acidosis that can be managed with higher respiratory rates, up to 30 breaths/min. Respiratory acidosis is often tolerated down to a pH of 7.2, so-called “permissive hypercapnia,” but progressive acidosis may require intravenous alkalinizing therapy (e.g., sodium bicarbonate or tromethamine) or accepting an increase in VT .

298
Q

VAP prevention interventions

A

head-of-bed elevation to at least 30–45° (70% VAP reduction compared to supine position), specialized endotracheal tube use with a suction port above the cuff to minimize aspirated secretions (50% VAP reduction), minimization of ventilator circuit tubing changes (prevents bacterial entry), and hand hygiene before handling the ventilatory circuit.

299
Q

Adverse effects of hypercapnia

A
300
Q

Patients passing an SBT have a >__% chance of successful extubation

A

70

301
Q

Epidemiologic Factors Suggesting Possible Causes of Community-Acquired Pneumonia

A
302
Q

Gross hemoptysis is associated with what type of pneumonia

A

Gross hemoptysis is suggestive of necrotizing pneumonia (e.g., that due to CA-MRSA).

303
Q

In px with CAP Only 5–14% of cultures from hospitalized CAP patients are positive, and the most common pathogen is

A

S. pneumoniae

304
Q

Criteria for severe CAP based from Harrisons

A
305
Q

Methicillin resistance in S. aureus is determined by the _____ gene, which encodes for resistance to all β-lactam drugs

A

mecA

306
Q

Outpx tx for CAP

A

Note FQ only for those with comorbid if outpatient

Monotherapy with a macrolide is recommended in the new guidelines only if there are contraindications to amoxicillin or doxycycline and there is documented low risk of macrolide resistance (<25%)

Routine coverage of anaerobes is unnecessary unless dentition is poor or there is a lung abscess or necrotizing pneumonia

307
Q

In px tx for CAP

A

If in px non severe, may give FQ alone

308
Q

When does CXR findings resolve in px with CAP?

A

Chest radiographic abnormalities are slowest to resolve (4–12 weeks), with the speed of clearance depending on the patient’s age and underlying lung disease

For a hospitalized patient, we generally recommend a follow-up radiograph ~4–6 weeks later. If relapse or recurrence is documented, particularly in the same lung segment, the possibility of an underlying neoplasm must be considered.

309
Q

Fever and leukocytosis will resolve after how many days in px with CAP

A

Fever and leukocytosis usually resolve within 2–4 days in otherwise healthy patients with CAP, but physical findings may persist
longer

310
Q

Prevention strategy for Oropharyngeal colonization with pathogenic bacteria

A
311
Q

Prevention strategy for large volume aspiration

A
312
Q

Prevention strategy for ventilator circuit humidification

A
313
Q

Prevention strategy for altered respiratory host

A
314
Q

Empiric tx for HAP and VAP

A

A 7- or 8-day course of therapy is just as effective as a 2-week course and is associated with less frequent emergence of antibioticresistant strains.

315
Q

Most impt preventive intervention for VAP

A

Because endotracheal intubation is a risk factor for VAP, the most important preventive intervention is to avoid intubation or minimize its duration

316
Q

When should you request for sputum GS/CS in px with CAP as per 2020 PSMID guidelines

A

CAP MR and HR and MDRO risk

not for CAP LR

317
Q

When should you request for blood CS in px with CAP as per 2020 PSMID guidelines

A

We recommend blood cultures
for patients with moderate and high risk CAP.

318
Q

Based on 2020 PSMID guidelines, what are the empiric abx for CAP LR

A
319
Q

Based on 2020 PSMID guidelines, what are the empiric abx for CAP MR

A

for CAP MR -> 3rd gen

320
Q

Definition of sepsis and septic shock

A
321
Q

Most common cause of sepsis

A

pneumonia

322
Q

The most common secondary infections included ________

A

The most common secondary infections included catheter-related bloodstream infections, ventilator-associated infections, and abdominal infections

323
Q

Gold std for diagnosing sepic

A

There is no specific test for sepsis, nor is there a gold-standard method for determining whether a patient is septic

324
Q

For every 1-h delay among septic patients, a ___% increase in the odds of in-hospital death is reported

A

3-7%

325
Q

5 components of sepsis bundles

A

This management bundle includes five components: (1) measurement of serum lactate levels, (2) collection of blood for culture before antibiotic administration, (3) administration of appropriate broad-spectrum antibiotics, (4) initiation of a 30 mL/kg crystalloid bolus for hypotension or lactate ≥4 mmol/L, and (5) treatment with vasopressors for persistent hypotension or shock.

Serum lactate levels should be remeasured if initial level ≥2 mmol/L

326
Q

Empiric abx for severe sepsis with no obvious source

A

TZP if immunocompetent is 4.5g IV q6
but if immunocompromised 3.375 q4

327
Q

Hypovolemic shock is most commonly related to

A

Hypovolemic shock is most commonly related to hemorrhage, which may be external (secondary to trauma) or internal (most commonly upper or lower gastrointestinal [GI]) bleeding

328
Q

Regardless of type, shock progresses through a continuum of three stages which are

A

Regardless of type, shock progresses through a continuum of three stages. These stages are compensated shock (preshock), shock (decompensated shock), and irreversible shock

329
Q

How do you perform passive leg raise test

A

The passive leg raise (PLR) test can predict responsiveness to additional intravenous fluid (IVF) by providing the patient with an endogenous volume bolus.

While the patient is resting in a semirecumbent position at a 45° angle, the bed is placed in Trendelenburg position such that the patient’s head becomes horizontal and the legs are extended at a 45° angle. There is then an immediate (within 1 min) assessment of changes in CO (or pulse pressure variation as a surrogate). It is important to emphasize that one does not merely look for changes in blood pressure; if the shock patient is mechanically ventilated there is the option of looking at changes in SV variation (or pulse pressure variation) during the respiratory cycle to assess volume responsiveness.

A >12% SV variation suggests a volume-responsive state.

330
Q

What pressure is used as a surrogate for LA pressure when using a pulmonary artery catheter

A

The PCWP is used as a surrogate for LA pressure.

331
Q

Definition of cardiogenic shock

A

The clinical presentation is typically characterized by persistent hypotension (<90 mmHg systolic blood pressure [BP]) or <60-65 mmHg mean arterial pressure unresponsive to volume replacement or by the use of vasopressors needed to maintain adequate BP (systolic >90 mmHg) and is accompanied by clinical features of peripheral hypoperfusion, such as elevated arterial lactate (>2 mmol/L).

332
Q

5 categories of cardiogenic shock

A
333
Q

Equalization of diastolic pressures in pulmonary artery catheter suggests

A

cardiac tamponade

334
Q

Advantages of culprit only PCI with staged revascularization vs immediate multivessel PCI in px with cardiogenic shock

A

Approximately 80% of Cardiogenic shock patients present with multivessel coronary artery disease. In these patients, culprit-only PCI with possible staged revascularization is the method of choice because it reduces mortality and requirement for renal replacement therapy at 30 days and 1 year in comparison to immediate multivessel PCI, as shown in the CULPRIT-SHOCK trial. The major driver for the reduction in the composite endpoint was a reduction in 30-day mortality

335
Q

Why is dopamine avoided as first line tx for MI with cardiogenic shock?

A

Dopamine should be avoided as first-line therapy for MI with CS based on hemodynamic and proarrhythmogenic effects

336
Q

Management of isolated RV cardiogenic shock

A

Management of isolated RV CS includes fluid administration to optimize right atrial pressure (10–15 mmHg); avoidance of excess fluids, which shifts the interventricular septum into the LV; catecholamines; early reestablishment of infarct-artery flow; and right-sided MCS

337
Q

Difference between Acute fulminant myocarditis vs Acute MI as a cause of cardiogenic shock

A

Acute myocarditis causes CS in a small proportion of cases. These patients are typically younger than those with CS due to acute MI and often do not have typical ischemic chest pain. Echocardiography usually shows global LV dysfunction. Initial management is the same as for CS complicating acute MI but does not involve revascularization.

338
Q

Beneficial effects of MV with PEEP on pulmonary edema

A

Mechanical ventilation with positive end-expiratory pressure can have multiple beneficial effects on pulmonary edema, as it: (1) decreases both preload and afterload, thereby improving cardiac function; (2) redistributes lung water from the intraalveolar to the extraalveolar space, where the fluid interferes less with gas exchange; and (3) increases lung volume to avoid atelectasis.

339
Q

Treatment for high altitude pulmonary edema

A

High-altitude pulmonary edema often can be prevented by use of dexamethasone, calcium channel–blocking drugs, or long-acting inhaled β2 -adrenergic agonists. Treatment includes descent from altitude, bed rest, oxygen, and, if feasible, inhaled NO; nifedipine may also be effective.

340
Q

Target O2 for pulmonary edema

A

> 92%

> 98% is detrimental

341
Q

Diuretic of choice for pulmonary edema

A

Furosemide is also a venodilator that rapidly reduces preload before any diuresis occurs and is the diuretic of choice.

The initial dose of furosemide should be ≤0.5 mg/kg, but a higher dose (1 mg/ kg) is required in patients with renal insufficiency, chronic diuretic use, or hypervolemia or after failure of a lower dose.

342
Q

Cardiac output increases by ___% in pregnancy, with most of the increase due to an increase in stroke volume

A

40

343
Q

In pregnant px The diagnosis of hypertension requires the measurement of two elevated blood pressures at least __ h apart.

A

4

344
Q

Meaning of HELLP syndrome

A

The HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) is a special subtype of preeclampsia with severe features and is a major cause of morbidity and mortality.

345
Q

Preeclampsia can be diagnosed without proteinuria in the presence of symptoms or laboratory abnormalities raising concern for end-organ damage which include

A

Specific clinical features qualify as evidence of severe disease, including severe hypertension (blood pressure ≥160/110 mmHg), new-onset symptoms (headache not responsive to medications, visual changes, unremitting severe epigastric pain, or pulmonary edema), or laboratory abnormalities signifying thrombocytopenia (platelets <100 × 109 /L), renal insufficiency (creatinine >1.1 mg/dL), or liver impairment (elevation of transaminases to twice the normal concentration).

346
Q

Definition of gestational hypertension

A

The development of elevated blood pressure after 20 weeks of pregnancy in the absence of preexisting chronic hypertension or proteinuria is referred to as gestational hypertension.

347
Q

The definitive treatment of preeclampsia

A

The definitive treatment of preeclampsia is delivery of the fetus and placenta

Expectant management of preeclampsia with severe features remote from term affords some benefits for the fetus but at significant risk to the mother. For women with preeclampsia with severe features, delivery is recommended unless the patient is <34 weeks and eligible for expectant management in a tertiary hospital setting.

Indications for delivery prior to 34 weeks include unremitting symptoms, development of laboratory abnormalities, or severe range blood pressures refractory to medical management

348
Q

first-line agents to manage severe hypertension in preeclampsia

A

Labetalol or hydralazine IV are the first-line agents to manage severe hypertension in preeclampsia with consideration of oral agents once blood pressure is controlled.

349
Q

preferred agent to prevent eclampsia in patients with preeclampsia with severe features and for treatment and prevention of recurrent seizures in patients with eclampsia.

A

Magnesium sulfate is the preferred agent to prevent eclampsia in patients with preeclampsia with severe features and for treatment and prevention of recurrent seizures in patients with eclampsia. Magnesium sulfate is administered as an IV loading dose followed by a continuous infusion, with care taken in patients with impaired renal function or pulmonary edema

350
Q

Target BP in chronic hypertension in pregnancy

A

The target blood pressure is in the range of 130–150 mmHg systolic and 80–100 mmHg diastolic to balance maternal safety with fetal perfusion

351
Q

Women with moderate to severe mitral stenosis (mitral valve area ≤1.5 cm2 ) who are planning pregnancy and have either symptomatic disease or pulmonary hypertension should undergo _______ prior to conception,

A

valvuloplasty

352
Q

For women with symptomatic aortic stenosis or severe aortic stenosis with a peak gradient >__ mmHg, treatment before pregnancy should be considered.

A

50

353
Q

For most diseases, an aortic root diameter <___ mm portends a favorable pregnancy outcome, whereas a diameter >__ mm is an indication for prepregnancy repair

A

40

50

354
Q

Impaired glycemic control during the critical first _____ weeks of pregnancy leads to the increased risk of spontaneous abortion and congenital anomalies seen in pregnancies affected by DM and highlights the importance of prepregnancy glycemic control

A

5-8

355
Q

Target glucose parameters in pregnant px

A

Fasting blood glucose levels should be maintained at <5.3 mmol/L (<95 mg/dL), with postprandial targets of <7.8 mmol/L (140 mg/dL) or <6.7 mmol/L (120 mg/dL) at 1 and 2 h, respectively

356
Q

Average daily insulin needs during pregnancy

A

Average daily insulin needs increase from 0.7–0.8 units/ kg in the first trimester, to 0.8–1 units/kg in the second trimester, and 0.9–1.2 units/kg in the third trimester

357
Q

What additional test should be requested for post partum px with GDM?

A

GDM confers a 7- to 10-fold increase in the risk of developing type 2 DM later in life, with a 10% risk within 5 years of delivery. All women with GDM should have a 4- to 12-week 2-h 75-g GTT to screen for DM or impaired glucose tolerance.

358
Q

Since the increased thyroxine requirement occurs as early as the fifth week of pregnancy, one approach is to increase the thyroxine dose by ___% as soon as pregnancy is diagnosed and then adjust the dose according to TSH.

A

30

(two additional pills weekly)

359
Q

Treatment for pregnant px with VTE

A

Anticoagulant therapy with low-molecular-weight heparin (LMWH) or unfractionated heparin is indicated in pregnant women with VTE

Anticoagulants increase the risk of epidural hematoma in women receiving neuraxial analgesia in labor and must be withheld prior to placement. Prophylactic LMWH must be stopped 12 h before placement of an epidural catheter, whereas therapeutic LMWH must be withheld for a full 24 h.

360
Q

The most common causes of PH are

A

left heart or primary lung disease

361
Q

the primary test used to screen and diagnose chronic thromboembolic pulmonary hypertension (CTEPH)

A

Ventilation-perfusion (V. /Q . ) scanning is the primary test used to screen and diagnose CTEPH, which should be considered in any patient with PH of unclear etiology

The definitive diagnostic procedure remains pulmonary angiography since contrast enhancement in this study provides detailed information on webbing, stricture, and vascular tapering patterns pathognomonic for CTEPH.

362
Q

How do you differentiate different types of PH according to hemodynamic phenotypes?

A
363
Q

WHO PH classification with PAWP >15 mmhg

A

PH due to left heart dse

The hallmark of this PH phenotype is elevated left atrial pressure with resulting pulmonary venous hypertension

364
Q

Trial that demonstrated improved symptoms, 6-MWD, and WHO FC in patients treated with bosentan

A

The randomized, placebo-controlled, phase 3 Bosentan Randomized Trial of Endothelin Antagonist Therapy (BREATHE)-1 trial comparing bosentan to placebo demonstrated improved symptoms, 6-MWD, and WHO FC in patients treated with bosentan

The Endothelin Antagonist Trial in Mildly Symptomatic Pulmonary Arterial Hypertension Patients (EARLY) study comparing bosentan to placebo demonstrated improved PVR and 6-MWD in patients with WHO FC II

365
Q

Trial that demonstrated that ambrisentan improves exercise tolerance, WHO FC, hemodynamics, and quality of life in patients with PAH

A

Several studies, including the phase 3, placebo-controlled Ambrisentan in Pulmonary Arterial Hypertension, (ARIES)-1 trial, have demonstrated that ambrisentan improves exercise tolerance, WHO FC, hemodynamics, and quality of life in patients with PAH.

366
Q

Trial that investigated macitentan effects on PAH

A

More recently, the Study with an Endothelin Receptor Antagonist in Pulmonary Arterial Hypertension to Improve Clinical Outcome (SERAPHIN) trial randomized 742 PAH patients to receive placebo or macitentan, which is an ETA/B antagonist with optimized receptor binding affinity. The majority of patients were on some form of background PAH therapy. Over an average treatment duration of 85 weeks, the hazard ratio for achieving the composite primary endpoint of PAH-related clinical worsening, which included death or disease progression, was decreased by 45% in the 10-mg dose arm.

367
Q

the sole approved pharmacotherapy for CTEPH patients for whom surgical pulmonary endarterectomy is ineffective or contraindicated

A

Riociguat

368
Q

Trial that demonstrated benefits of combination of taladafil and ambrisentan in PAH

A

The role of early, aggressive therapy with combination oral treatments was addressed in the landmark Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension (AMBITION) trial. Treatment-naïve, incident PAH patients (n = 500) were randomized to a combination of ambrisentan and tadalafil, ambrisentan monotherapy, or tadalafil monotherapy. Up-front combination therapy with ambrisentan and tadalafil was associated with a 50% lower risk of clinical worsening (composite of death, lung transplantation, hospitalization for PAH worsening, and worsening PAH) when compared with the monotherapy group

369
Q

When do you start px on IV prostacyclin based on vasoreactivity test?

A

negative vasoreactivity test, high risk (syncope + advanced HF)

Low- or intermediate (Int)-risk patients are initiated on combination oral therapy, which generally includes an endothelin receptor antagonist and phosphodiesterase type 5 inhibitor

370
Q

FDA approved therapies for PAH

A
371
Q

Empiric tx for CAP HR

A
372
Q

Routine anaerobic coverage for suspected aspiration pneumonia is NOT recommended, unless ______ is suspected

A

lung abscess or empyema

373
Q

empiric treatment of patients with moderate to high risk CAP and with risk factors for MRSA

A
374
Q

empiric treatment of patients with moderate to high risk CAP and with risk factors for ESBL

A

Note: ESBL + culture within 1 yr –> risk of ESBL pa rin

375
Q

empiric treatment of patients with moderate to high risk CAP and with risk factors for P. aeruginosa

A

Note: prior tracheostomy: risk factor for P. aeruginosa

376
Q

Based on PSMID 2020 guidelines ,As soon as diagnosis is established, treatment of community acquired pneumonia, regardless of risk, should be initiated within 4 hours

A

As soon as diagnosis is established, treatment of community acquired pneumonia, regardless of risk, should be initiated within 4 hours

377
Q

Based on PSMID 2020 guidelines, Among patients with low to moderate risk CAP, a treatment duration of ___ days is recommended as long as the patient is clinically stable (afebrile within 48 hours, able to eat, normal blood pressure, normal heart rate, normal respiratory rate, normal oxygen saturation, and return to baseline sensorium).

A

Among patients with low to moderate risk CAP, a treatment duration of 5 days is recommended as long as the patient is clinically stable (afebrile within 48 hours, able to eat, normal blood pressure, normal heart rate, normal respiratory rate, normal oxygen saturation, and return to baseline sensorium).

378
Q

Based on PSMID 2020 guidelines, what are the recommended vaccines to prevent pneumonia?

A

Administration of both influenza and pneumococcal vaccine is recommended to prevent pneumonia, hospitalization and mortality in adults 50 years old and above.

379
Q

When is influenza testing recommended in px with high risk CAP as per PSMID 2020 guidelines?

A

We recommend testing of respiratory secretions for influenza through rapid molecular testing using rapid nucleic acid amplification tests during periods of high influenza activity (July to January) for patients with high risk CAP preceded by influenza-like illness symptoms (sore throat, rhinorrhea, body malaise, joint pains) and any of the following risk factors:
* Aged 60 years and above
* Pregnant
* Asthmatic
* Other co-morbidities: uncontrolled diabetes mellitus, active malignancies, neurologic disease in evolution, congestive heart failure class II-IV, unstable coronary artery disease, renal failure on dialysis, uncompensated COPD, decompensated liver disease

380
Q

The most strongly and consistently associated risk factors for CAP due to MRSA were

A

The most strongly and consistently associated risk factors for CAP due to MRSA were previous MRSA colonization or infection, especially of the respiratory tract, within 1 year